Mylan receives FDA approval for Verapamil Hydrochloride capsules

Editorial Checklist Reviewed
Aug 13 2007NewsGuard 100/100 Score

Mylan Laboratories Inc. has announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Verapamil Hydrochloride (HCl) Extended-release (ER) Capsules (PM), 100 mg, 200 mg and 300 mg.

Verapamil HCl ER Capsules (PM) are the generic version of Elan Drug Delivery Inc.'s Verelan(R) PM ER Capsules. Verapamil HCl ER Capsules (PM) had U.S. sales of approximately $58 million for the 12 months ending June 30, 2007, for the same strengths.

This product will be shipped immediately.

Mylan Laboratories Inc. is a leading pharmaceutical company with three principal subsidiaries, Mylan Pharmaceuticals Inc., Mylan Technologies Inc. and UDL Laboratories Inc., and a controlling interest in Matrix Laboratories Limited, India. Mylan develops, licenses, manufactures, markets and distributes an extensive line of generic and proprietary products.

Source:

http://www.mylan.com/

Posted in: Pharmaceutical News

Tags: , , , , ,

Comments (0)

Suggested Reading

Living in food deserts during early childhood raises long-term obesity risk
Ultra-processed foods dominate children's diets from toddlerhood to middle childhood
Not all ultra-processed foods are made alike: Researchers warn against villainizing entire food group
High levels of microplastics found in prostate tumors, possibly linked to take-out food
Key triggers for food allergies in children after organ transplants
Limiting fast-food outlets can reduce childhood overweight and obesity
Social media normalizes unhealthy food choices, shaping youth habits and brand loyalty
Six common flying with food allergies myths

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Frequent ultra-processed food consumption raises mortality risks, especially in women